The Oncogenic Effects, Pathways, and Target Molecules of JC Polyoma Virus T Antigen in Cancer Cells

Hua-Chuan Zheng1, Hang Xue1, Yu-Zi Jin2

  • 1Department of Oncology and Experimental Center, The Affiliated Hospital of Chengde Medical University, Chengde, China.

Frontiers in Oncology
|March 30, 2022
PubMed

Insights

JC polyoma virus T-antigen drives cancer progression by altering cell metabolism, proliferation, and survival pathways. This study reveals key molecular targets and interactions driving aggressive cancer phenotypes.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • JC polyoma virus (JCPyV) is a ubiquitous virus linked to progressive multifocal leukoencephalopathy and malignancies.
  • The viral T-antigen is a key oncoprotein implicated in JCPyV-associated cancers.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which JCPyV T-antigen influences cancer cell behavior and phenotype.
  • To identify specific signaling pathways, metabolic processes, and protein interactions modulated by T-antigen in cancer cells.

Main Methods:

  • Investigated the effects of T-antigen knockdown and overexpression on cancer cell proliferation, apoptosis, migration, and invasion.
  • Utilized transcriptomic, metabolomic, and proteomic analyses to identify T-antigen-regulated cellular processes.
  • Examined T-antigen interactions with host proteins in lens tumor cells.

Main Results:

  • T-antigen knockdown suppressed cancer cell proliferation and induced apoptosis, while overexpression promoted these processes.
  • T-antigen modulated key signaling pathways including PI3K-Akt, mTOR, p38, and pathways related to cell cycle regulation (e.g., Cyclin D1, p21).
  • Metabolomic and proteomic analyses revealed T-antigen's impact on amino acid biosynthesis, ribosome biogenesis, and carbon metabolism, alongside interactions with keratins, ribosomal proteins, and signaling molecules like β-catenin and p53.

Conclusions:

  • JCPyV T-antigen promotes an aggressive cancer phenotype through oncogene activation, tumor suppressor inactivation, and disruption of cellular metabolism and adhesion.
  • T-antigen targets multiple host pathways, including viral carcinogenesis, microRNA regulation, and focal adhesion signaling, contributing to tumorigenesis.
  • Understanding these mechanisms provides potential therapeutic targets for JCPyV-associated cancers.

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.4K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.4K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K